Citadel Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.4M Sell
36,800
-6,200
-14% -$813K ﹤0.01% 4553
2025
Q4
$5.86M Buy
43,000
+7,800
+22% +$1.12M ﹤0.01% 4040
2025
Q3
$5.19M Sell
35,200
-10,900
-24% -$1.51M ﹤0.01% 4300
2025
Q2
$5.96M Buy
46,100
+3,500
+8% +$424K ﹤0.01% 3812
2025
Q1
$5.09M Buy
42,600
+23,400
+122% +$2.9M ﹤0.01% 3842
2024
Q4
$2.23M Sell
19,200
-10,500
-35% -$1.33M ﹤0.01% 5406
2024
Q3
$4.01M Buy
29,700
+11,100
+60% +$1.49M ﹤0.01% 4306
2024
Q2
$2.52M Sell
18,600
-7,500
-29% -$1.02M ﹤0.01% 4888
2024
Q1
$3.37M Sell
26,100
-6,400
-20% -$773K ﹤0.01% 4589
2023
Q4
$3.72M Sell
32,500
-10,400
-24% -$1.04M ﹤0.01% 4273
2023
Q3
$3.91M Buy
42,900
+15,752
+58% +$1.62M ﹤0.01% 4046
2023
Q2
$3.06M Sell
27,148
-67,552
-71% -$7.14M ﹤0.01% 4440
2023
Q1
$9.92M Sell
94,700
-32,200
-25% -$3.36M ﹤0.01% 2825
2022
Q4
$14M Buy
126,900
+116,600
+1,132% +$12.2M ﹤0.01% 2382
2022
Q3
$900K Sell
10,300
-3,300
-24% -$300K ﹤0.01% 7220
2022
Q2
$1.06M Sell
13,600
-10,600
-44% -$875K ﹤0.01% 6886
2022
Q1
$2.06M Sell
24,200
-100
-0.4% -$9.58K ﹤0.01% 6022
2021
Q4
$2.91M Buy
24,300
+9,800
+68% +$1.22M ﹤0.01% 5398
2021
Q3
$1.79M Buy
14,500
+500
+4% +$64.3K ﹤0.01% 6647
2021
Q2
$1.68M Hold
14,000
﹤0.01% 7034
2021
Q1
$1.47M Sell
14,000
-14,200
-50% -$1.44M ﹤0.01% 7155
2020
Q4
$2.87M Sell
28,200
-15,200
-35% -$1.43M ﹤0.01% 4657
2020
Q3
$3.65M Buy
43,400
+29,700
+217% +$2.31M ﹤0.01% 3639
2020
Q2
$890K Buy
13,700
+500
+4% +$33K ﹤0.01% 6044
2020
Q1
$860K Sell
13,200
-8,900
-40% -$701K ﹤0.01% 5600
2019
Q4
$1.74M Sell
22,100
-3,800
-15% -$296K ﹤0.01% 4644
2019
Q3
$2.06M Sell
25,900
-6,400
-20% -$503K ﹤0.01% 4443
2019
Q2
$2.7M Buy
32,300
+400
+1% +$31.9K ﹤0.01% 4033
2019
Q1
$2.52M Buy
31,900
+5,600
+21% +$409K ﹤0.01% 4079
2018
Q4
$1.75M Sell
26,300
-5,500
-17% -$381K ﹤0.01% 4361
2018
Q3
$2.54M Buy
31,800
+11,100
+54% +$829K ﹤0.01% 4003
2018
Q2
$1.4M Buy
20,700
+3,100
+18% +$225K ﹤0.01% 4664
2018
Q1
$1.35M Buy
17,600
+14,200
+418% +$1.05M ﹤0.01% 4335
2017
Q4
$232K Sell
3,400
-6,200
-65% -$412K ﹤0.01% 6883
2017
Q3
$601K Buy
+9,600
New +$574K ﹤0.01% 5047
2017
Q2
Sell
-4,800
Closed -$241K 8167
2017
Q1
$241K Buy
4,800
+300
+7% +$14.6K ﹤0.01% 6221
2016
Q4
$223K Sell
4,500
-2,700
-38% -$137K ﹤0.01% 6145
2016
Q3
$378K Buy
7,200
+600
+9% +$29.4K ﹤0.01% 5296
2016
Q2
$295K Buy
+6,600
New +$287K ﹤0.01% 5241
2016
Q1
Sell
-2,400
Closed -$88K 8119
2015
Q4
$88K Sell
2,400
-1,600
-40% -$57.9K ﹤0.01% 6831
2015
Q3
$131K Sell
4,000
-3,100
-44% -$104K ﹤0.01% 6672
2015
Q2
$263K Sell
7,100
-7,200
-50% -$262K ﹤0.01% 5940
2015
Q1
$501K Buy
14,300
+3,700
+35% +$131K ﹤0.01% 4906
2014
Q4
$404K Sell
10,600
-4,700
-31% -$172K ﹤0.01% 5022
2014
Q3
$543K Buy
15,300
+10,100
+194% +$375K ﹤0.01% 4512
2014
Q2
$203K Sell
5,200
-2,400
-32% -$89.7K ﹤0.01% 5553
2014
Q1
$277K Buy
7,600
+5,200
+217% +$190K ﹤0.01% 5108
2013
Q4
$83K Buy
2,400
+200
+9% +$6.43K ﹤0.01% 5751
2013
Q3
$61K Sell
2,200
-3,100
-58% -$82.6K ﹤0.01% 5675
2013
Q2
$143K Buy
+5,300
New +$146K ﹤0.01% 4944

Other funds holding XYL

Citadel Advisors's XYL Position: Q1 2026 in Review

Citadel Advisors increased its Xylem (XYL) stake by 242% in Q1 2026, buying an estimated $44.7M and bringing the position to 481,831 shares worth $57.6M. The position accounts for 0.01% of the portfolio, ranked #1234.

Citadel Advisors first reported a position in XYL in Q2 2013 and has held it in 47 quarters since. The position peaked at $148M in Q2 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Citadel Advisors held 481,831 shares of Xylem worth $57.6M as of Q1 2026.
  • Citadel Advisors bought 340,741 Xylem shares in Q1 2026, an estimated $44.7M.
  • Xylem made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1234 holding.
  • Citadel Advisors first reported a position in Xylem in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Xylem position peaked at $148M in Q2 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.